Ethical issues present at the moment includes the questioning of whether experiments treatment should be used in the current situation. Ever since the Ebola outbreak that has infected 2 Americans, American company has stepped out and the trial drug (ZMapp) came to the public’s attention. This has caused a heated debate. Personally, my take on the trial drug is that at times like this when the outbreak might trigger a red alert, causing more nations to be affected, it should be used. With the trial drug being experimented on humans, if it’s a success, this will serve as a cure and stop the spread of Ebola. Yes, I do agree that of it’s a failure, a life would be lost, but think about it, without the drug, the condition of the affected would worsen and eventual death. So why not give it a shot instead. Sacrifices have to be made for the great things.
However, on a side note, I would like to bring up the point that the fact that the Americans only allowed the drug to surface to the public when their people are infected, this is indeed a selfish act, and failure to meet obligation under 2005 World Health Organisation (WHO) regulations to help build global capacities to respond to infectious diseases. But standing in the perspective of the very nation, they might be afraid of the consequences the drug will bring about on human for it is not tested. Hence, having the reservation to usage of trial drug, especially on infected patients of foreign nations. Perhaps for fear that it will worsen the relations between nations.
However, accorded to news dated two days ago (16 August 2014) the first ever patient, Dr. Kent Brantly, 33, has his condition improving drastically within an hour of using the serum when previously his condition was deteriorating rapidly. Unsure whether it is indeed the effects of the serum, ZMapp. Nevertheless, this signifies that the drug may indeed be the cure to this deadly illness.